Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Clinical trial NCT01585272 · COMPLETED
Trial details
- NCT number
- NCT01585272
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2015-06-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.